Education
About Us
Working with TipRanks
Follow Us
Oragenics Inc (OGEN)
:OGEN
Total Valuation
Oragenics has a market cap or net worth of $4.08M. The enterprise value is $4.95M.
Market Cap$4.08M
Enterprise Value$4.95M
Share Statistics
Oragenics has 21.48M shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding21.48M
Owened by Insiders1.41%
Owened by Instutions0.51%
Financial Efficiency
Oragenics’s return on equity (ROE) is 49.88 and return on invested capital (ROIC) is -9052.25%.
Return on Equity (ROE)4987.57%
Return on Assets (ROA)-717.68%
Return on Invested Capital (ROIC)-9052.25%
Return on Capital Employed (ROCE)4983.28%
Revenue Per Employee-$12,551
Profits Per Employee-$6,655,407.333
Employee Count3
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Oragenics is -0.23. Oragenics’s PEG ratio is <0.01.
PE Ratio-0.23
PS Ratio0.00
PB Ratio-11.54
Price to Fair Value-11.54
Price to FCF-0.28
Price to Operating Cash Flow-0.28
PEG Ratio<0.01
Income Statement
In the last 12 months, Oragenics had revenue of -$37.65K and earned -$19.97M in profits. Earnings per share was -$5.73.
Revenue-$37.65K
Gross Profit-$12.65M
Operating Income-$9.73M
Pretax Income-$19.97M
Net Income-$19.97M
EBITDA-20.14M
Earnings Per Share (EPS)-5.73
Cash Flow
In the last 12 months, operating cash flow was -$7.68M and capital expenditures $0.00, giving a free cash flow of -$7.68M billion.
Operating Cash Flow-$7.68M
Free Cash Flow-$7.68M
Free Cash Flow per Share-$0.36
Dividends & Yields
Oragenics pays an annual dividend of , resulting in a dividend yield of
Dividend Per Share
Dividend Yield
Payout Ratio
Free Cash Flow Yield-351.56%
Earnings Yield-432.14%
Stock Price Statistics
Beta2.14
52-Week Price Change-84.55%
50-Day Moving Average0.26
200-Day Moving Average0.52
Relative Strength Index (RSI)27.76
Average Volume (3m)428.26K
Important Dates
Oragenics upcoming earnings date is Aug 12, 2024, TBA.
Last Earnings DateMay 13, 2024
Next Earnings DateAug 12, 2024
Ex-Dividend Date―
Financial Position
Oragenics as a current ratio of 0.87, with Debt / Equity ratio of -1.55
Current Ratio0.87
Quick Ratio0.87
Debt to Market Cap0.13
Net Debt to EBITDA0.05
Interest Coverage Ratio353.99
Taxes
In the past 12 months, Oragenics has paid -$10.97K in taxes.
Income Tax-$10.97K
Effective Tax Rate0.00%
Enterprise Valuation
Oragenics EV to EBITDA ratio is -0.18, with an EV/FCF ratio of -0.22.
EV to Sales0.00
EV to EBITDA-0.18
EV to Free Cash Flow-0.22
EV to Operating Cash Flow-0.22
Balance Sheet
Oragenics has $3.14M in cash and marketable securities with $519.39K in debt, giving a net cash position of -$2.62M billion.
Cash & Marketable Securities$3.14M
Total Debt$519.39K
Net Cash-$2.62M
Net Cash Per Share-$0.12
Tangible Book Value Per Share-$0.03
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for Oragenics is , which is 11.43% higher than the current price. The consensus rating is
Price Target
Price Target Upside
Analyst Consensus
Analyst Count0
Revenue Growth Forecast-100.00%
EPS Growth Forecast76.55%